Insider Shareholders with Direct Ownership of Checkmate Pharmaceuticals, Inc. (CMPI)
This section provides a comprehensive overview of the insiders with direct ownership of Checkmate Pharmaceuticals, Inc. (CMPI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Checkmate Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novo Holdings
> 10% Shareholder |
2,170,100 | 8,110 | 2,161,990 $22.7 Million | 4 |
Feb 25, 2022
Reduced 0.01%
|
|
Ven Bio Global Strategic Fund Ii L.P.
> 10% Shareholder |
0 | 1,517,444 | 2,155,930 $22.6 Million | 20 |
May 16, 2022
Reduced 4.25%
|
|
Arthur M Krieg
Chief Scientific Officer |
95,137 | 0 | 815,734 $8.56 Million | 12 |
Jun 18, 2021
Added 0.88%
|
|
Kleem Chaudhary
Chief Business Officer |
8,000 | 0 | 8,000 $83,920 | 3 |
Feb 26, 2021
Added 20.0%
|